Sector portfolio · Corporate investor · United States
Eli Lilly's Biotech portfolio
Eli Lilly has backed 55 Biotech startups in rounds we track, $6.7B between them, shown by the stage each has reached. The best-funded is Avidity Biosciences.
55startups backed
5stages
$6.7Braised between them
Stage not reportedbiggest stage
Series A
15
Series B
15
Funding by segment
- Stage not reported$699M15
- Series A$1.4B15
- Series B$2.1B15
- Series C and later$2.4B8
- Pre-seed and seed$52M2
Where they are based
- United States39$4.5B
- United Kingdom5$430M
- Canada2$532M
- Netherlands1$68M
- Switzerland1$67M
- South Korea1$18M
- Singapore1$14M
- France1$37M
- Australia1$438M
- Hong Kong SAR China1$392M
United States
United Kingdom
Canada
Netherlands
Switzerland
South Korea
Singapore
France
Australia
Hong Kong SAR ChinaFounded
3Earlier
412
113
14
315
416
417
518
819
520
621
622
123
24
125
26
4 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M8
- $10M to $50M16
- $50M to $250M24
- $250M to $1B7
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
51 of 55 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States39
- United Kingdom5
- Canada2
- Netherlands1
- Switzerland1
- South Korea1
- Singapore1
- France1
- Australia1
- Hong Kong SAR China1
Startups by country, 10 countries in all.
Segment by segment
Stage not reported
15 startups · $699M raised
Cabaletta BioCabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.United States$200M
Vanqua BioVanqua Bio is a biopharmaceutical company based in Chicago, founded in 2019.United States$130M
Syndeio BiosciencesSyndeio Biosciences (from the Ancient Greek word "to connect") is a clinical-stage biotechnology company developing therapies to rUnited States$90M
ProQR TherapeuticsChanging lives is what drives us at ProQR Therapeutics.Netherlands$68M
HAYA TherapeuticsHAYA Therapeutics, SA is a precision medicine and biotechnology company focused on developing innovative genomic medicines.Switzerland$67M
Centrexion TherapeuticsCentrexion Therapeutics is a late clinical-stage biopharmaceutical company addressing the treatment of chronic pain.-$41M
LTZ TherapeuticsLTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.United States$38M
ABL BioABL Bio is a biotech research company that focuses on the development of therapeutic drugs for immuno-oncology diseases.South Korea$18M
Series A
15 startups · $1.4B raised
AbCelleraAbCellera is an antibody discovery and development company that develops antibody therapeutics to improve patient outcomes.Canada$526M
Verve TherapeuticsVerve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease.United States$202M
Myricx BioMyricx Bio is a biotechnology company that develops novel NMT inhibitor payloads for ADCs to treat cancer.United Kingdom$115M
Firefly BioFirefly Bio specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders.United States$94M
Stylus MedicineStylus Medicine is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative in vivo genetic medicines.United States$85M
Faze MedicinesFaze Medicines was a biotechnology company based in Cambridge, Massachusetts, founded in 2020.United States$81M
Dualitas TherapeuticsDualitas Therapeutics is a biotechnology company based in South San Francisco, CA, founded in 2023.United States$65M
Solu TherapeuticsSolu Therapeutics is a Boston-based clinical-stage biotechnology company focused on developing precision medicines to target and eUnited States$41M
Series B
15 startups · $2.1B raised
Terns PharmaceuticalsTerns Pharmaceuticals is a biopharmaceutical company that focuses on discovering therapies that will improve the global disease burden.United States$730M
T-TherapeuticsT-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.United Kingdom$279M
Mariana OncologyMariana Oncology is a biotechnology research industry.United States$175M- CTCapstan TherapeuticsCapstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases.United States$175M
Aktis OncologyAktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals.United States$175M
SonoTheraSonoThera is a biotechnology company based in South San Francisco that focuses on developing ultrasound-guided, nonviral gene therapies.United States$125M- DPDTx PharmaDTx Pharma is a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease.-$100M
Cedilla TherapeuticsCedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.United States$81M
Series C and later
8 startups · $2.4B raised
Avidity BiosciencesSynapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.United States$790M
AdvanCellAdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.Australia$438M- IMInsilico MedicineHong Kong SAR China$392M
Beta BionicsBeta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet.United States$296M
Circle PharmaCircle Pharma is a provider of a macrocycle development platform intended to provide macrocyclic peptides.United States$187M
Lycia TherapeuticsLycia Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California.United States$182M- PSPerlegen SciencesPerlegen Sciences develops genetic variations providing physicians with information to improve the clinical process and treatment outcomes.United States$104M
Affinia TherapeuticsAffinia Therapeutics is a preclinical-stage biotechnology company based in Waltham, Massachusetts, founded in 2019.United States$40M
Pre-seed and seed
2 startups · $52M raised
Amber BioAmber Bio is a biotechnology company focused on advancing genetic medicine through innovative RNA-based therapeutic platforms.United States$26M
NanoSyrinxNanoSyrinx is a UK-based synthetic biology company focused on developing a novel drug delivery platform called Nanosyringes.United Kingdom$26M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Eli Lilly as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosSector portfolioEli Lilly's AI portfolio13 startups · $1.4BPortfolio mapEli Lilly portfolio map86 startups · $12BCo-investorsWho invests with Eli Lilly69 co-investorsSector portfolioCoinbase Ventures' Web3 & Crypto portfolio168 startups · $5.7BSector portfolioSalesforce Ventures' AI portfolio115 startups · $181BSector portfolioGoogle Ventures' AI portfolio81 startups · $16B
Raising from investors like Eli Lilly?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.